Moderna COVID shot approved for children as young as six months in Canada
carmengabriela


Health Canada has approved Moderna's (NASDAQ:MRNA) COVID-19 vaccine in children from six months to five years old.
In this age group, the primary series is 25 mcg each, given four weeks apart. The dosage is half the amount authorized for children six years to 11 years old.

A clinical trial showed that the immune response after children in the youngest age group were given Spikevax was similar to that seen in a study of 18 to 25-year-olds.
Health Canada said ~1.7M children are now eligible to receive the shot.

Pfizer (PFE) and BioNTech (BNTX) are awaiting Health Canada action on their authorization request for their vaccine in the six months to five years old group.